FR3074M - Médicament a base d'un nouveau dérivé hétérocyclique du benzocycloheptane. - Google Patents

Médicament a base d'un nouveau dérivé hétérocyclique du benzocycloheptane.

Info

Publication number
FR3074M
FR3074M FR955157A FR955157A FR3074M FR 3074 M FR3074 M FR 3074M FR 955157 A FR955157 A FR 955157A FR 955157 A FR955157 A FR 955157A FR 3074 M FR3074 M FR 3074M
Authority
FR
France
Prior art keywords
benzocycloheptane
product based
medicinal product
heterocyclic derivative
new heterocyclic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR955157A
Other languages
English (en)
Inventor
Ernst Jucker
Anton Ebnoether
Andre Stoll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Application granted granted Critical
Publication of FR3074M publication Critical patent/FR3074M/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/24Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80Seven-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006Esters of acyclic acids which can have further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
    • C07F9/655345Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR955157A 1962-08-31 1963-11-27 Médicament a base d'un nouveau dérivé hétérocyclique du benzocycloheptane. Expired FR3074M (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH1037762A CH416623A (de) 1962-08-31 1962-08-31 Verfahren zur Herstellung neuer heterocyclischer Verbindungen
CH848763 1963-07-08
FR946068A FR1371443A (fr) 1962-08-31 1963-08-29 Nouveaux dérivés hétérocycliques du benzocycloheptane et leur préparation

Publications (1)

Publication Number Publication Date
FR3074M true FR3074M (fr) 1965-01-18

Family

ID=25703394

Family Applications (2)

Application Number Title Priority Date Filing Date
FR946068A Expired FR1371443A (fr) 1962-08-31 1963-08-29 Nouveaux dérivés hétérocycliques du benzocycloheptane et leur préparation
FR955157A Expired FR3074M (fr) 1962-08-31 1963-11-27 Médicament a base d'un nouveau dérivé hétérocyclique du benzocycloheptane.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR946068A Expired FR1371443A (fr) 1962-08-31 1963-08-29 Nouveaux dérivés hétérocycliques du benzocycloheptane et leur préparation

Country Status (15)

Country Link
US (1) US3272826A (fr)
AT (2) AT244965B (fr)
BE (1) BE636717A (fr)
BR (1) BR6352419D0 (fr)
CH (1) CH416623A (fr)
DE (1) DE1227026B (fr)
DK (2) DK109513C (fr)
ES (1) ES291240A1 (fr)
FI (2) FI42439B (fr)
FR (2) FR1371443A (fr)
GB (3) GB1055056A (fr)
MY (1) MY377087A (fr)
NL (4) NL6909105A (fr)
OA (1) OA00700A (fr)
SE (2) SE350050B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3491103A (en) * 1963-12-19 1970-01-20 Sandoz Ag Certain 4h-benzo(4,5)cyclohepta-(1,2-b) thiophenes
US3464983A (en) * 1964-02-04 1969-09-02 Sandoz Ag 4h-benzo(4,5)cyclohepta(1,2-b)thiophenes
CH468400A (de) * 1965-12-23 1969-02-15 Sandoz Ag Verfahren zur Herstellung neuer Thieno(2,3-b)(1,5)benzothiazepin-4-on-Verbindungen
US3458522A (en) * 1967-05-17 1969-07-29 Sandoz Ag 4-piperidine substituted benzocycloheptaoxazoles and benzocycloheptathiazoles
CH531000A (de) * 1970-03-11 1972-11-30 Sandoz Ag Verfahren zur Herstellung neuer Benzocycloheptathiophene
BE794377A (fr) * 1972-01-24 1973-07-23 Sandoz Sa Nouveaux derives du benzo-cyclohepta-thiophene
JPS51142543A (en) * 1975-05-20 1976-12-08 Sandoz Ag Improvement in organic compound
US4073915A (en) * 1975-05-20 1978-02-14 Sandoz Ltd. Treating asthma
US4085218A (en) * 1975-10-30 1978-04-18 Sandoz Ltd. Elevating mood in geriatric patients
EP0412988A1 (fr) * 1988-04-28 1991-02-20 Schering Corporation Composes polycycliques fusionnes, compositions, procedes de fabrication et leurs utilisations comme antagonistes du paf, antihistamines et/ou agents anti-inflammatoires
US5006536A (en) * 1989-12-26 1991-04-09 Hoechst-Roussel Pharmaceuticals Inc. Thienobenzoxepins and analgesic compositions thereof
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
CA2093797C (fr) * 1990-10-10 1998-09-22 Richard J. Friary Derives de substitution d'imidazobenzazepines et d'imidazopyridoazepines
FR2668150B1 (fr) * 1990-10-17 1994-11-18 Theramex Nouveaux derives du terbutylphenyl 1-amino 4-hydroxybutane, leurs procedes de preparation et les compositions pharmaceutiques en renfermant.
US20070225217A1 (en) 2005-11-09 2007-09-27 Combinatorx, Incorporated Methods, compositions, and kits for the treatment of medical conditions
US20100166804A1 (en) * 2007-05-23 2010-07-01 Dennis Penn Methods
WO2009073154A1 (fr) * 2007-11-28 2009-06-11 Nektar Therapeutics Al, Corporation Composés tricycliques conjugués à un oligomère
WO2009142772A2 (fr) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Méthodes et traitement d’allergies et inflammations associées à des pathologies gastro-intestinales

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813873A (en) * 1957-11-19 Derivatives of the ibogaine alkaloids
US2937118A (en) * 1956-06-27 1960-05-17 Raschig Gmbh Dr F Aminopyridine compositions
US3014911A (en) * 1958-09-29 1961-12-26 Merck & Co Inc Derivatives of dibenzo[a, e]cycloheptatriene
BE600530A (fr) * 1960-02-25 1961-08-23 Sandoz Sa Nouveaux composés hétérocycliques dérivant du thiaxanthène et leur préparation
DE1227461B (de) * 1960-04-29 1966-10-27 Sandoz Ag Verfahren zur Herstellung von neuen Thioxanthenderivaten
US3063902A (en) * 1961-01-18 1962-11-13 Irwin Neisler & Co Analgesic aralkyl-pyridines
US3047580A (en) * 1961-09-29 1962-07-31 Merck & Co Inc 10-(omega-amino alkyl)-10-hydroxythiaxanthenes

Also Published As

Publication number Publication date
US3272826A (en) 1966-09-13
FI42439B (fr) 1970-04-30
BR6352419D0 (pt) 1973-08-16
BE636717A (fr)
FI44004B (fr) 1971-04-30
MY377087A (en) 1987-12-31
GB1055056A (en) 1967-01-11
SE350050B (fr) 1972-10-16
SE309237B (fr) 1969-03-17
GB1055055A (en) 1967-01-11
NL137020C (fr)
ES291240A1 (es) 1964-03-01
AT244965B (de) 1966-02-10
DE1518335A1 (de) 1970-04-16
NL130095C (fr)
FR1371443A (fr) 1964-09-04
DK109513C (da) 1968-05-06
CH416623A (de) 1966-07-15
OA00700A (fr) 1967-07-15
GB1055057A (en) 1967-01-11
DE1227026B (de) 1966-10-20
DE1518335B2 (de) 1975-08-28
NL6909105A (fr) 1969-08-25
AT250944B (de) 1966-12-12
DK117962B (da) 1970-06-22
NL297097A (fr)

Similar Documents

Publication Publication Date Title
FR3806M (fr) Médicament a base d'un dérivé de la quinazolone-(4).
FR3074M (fr) Médicament a base d'un nouveau dérivé hétérocyclique du benzocycloheptane.
FR278M (fr) Médicament a base de dérivé chloré d'imino-dibenzyle.
FR3348M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR3148M (fr) Médicament a base d'un nouveau dérivé de la 5.6-dihydromorphanthridine.
FR2186M (fr) Médicament a base d'un dérivé de l'aniline.
FR3680M (fr) Médicament a base d'un nouveau dérivé du thiaxanthe?
FR2094M (fr) Médicament a base d'un nouvel hendécapeptide.
FR1362187A (fr) Nouveau produit d'enregistrement photographique
FR3101M (fr) Médicament a base d'un nouveau composé aryl-tétralylique.
FR3040M (fr) Médicament a base de dérivés basiques du dibenzo-cycloheptane.
FR1891M (fr) Médicament a base d'un phénoxy-alcane.
FR2869M (fr) Médicament a base d'un dérivé de la cymarine.
FR3045M (fr) Médicament a base d'un nouveau dérivé de la phénothiazine.
FR3649M (fr) Médicament a base d'un nouveau dérivé de l'indole.
FR3078M (fr) Médicament a base d'un nouveau polypeptide.
FR1843M (fr) Médicament a base d'amides d'acides 1.4-benzodioxanne-carboxyliques.
FR3778M (fr) Médicament a base d'un nouveau dérivé de thiophene.
FR3351M (fr) Médicament a base d'un nouveau dérivé de la 1.2-diphényl-3.5-dioxo-pyrazolidine.
FR3798M (fr) Médicament a base d'un nouveau dérivé de l'anthracene.
FR3223M (fr) Médicament a base d'un dérivé du dihydro-anthracene.
FR3301M (fr) Médicament a base d'un nouveau polypeptide.
FR2904M (fr) Médicament a base d'un nouveau polypeptide.
FR2091M (fr) Médicament a base d'un dérivé du cyclohexene.
FR2035M (fr) Médicament a base de dérivé du méthyl-4 esculétol.